Brian Bosworth Selected Research

Brian Bosworth Research Topics

4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2018 - 02/2013
2	Inflammation (Inflammations) 01/2017 - 02/2013
2	Ulcerative Colitis 01/2017 - 11/2015
2	Crohn Disease (Crohn's Disease) 01/2017 - 09/2007
2	Proctocolitis (Hemorrhagic Proctocolitis) 11/2015 - 04/2015
2	Proctitis 11/2015 - 04/2015
1	Stroke (Strokes) 01/2020
1	Hypertrophy 01/2020
1	COVID-19 01/2020
1	Clostridium Infections 01/2017
1	Disease Resistance 01/2017
1	Neoplasms (Cancer) 01/2016
1	Acute Kidney Injury (Acute Renal Failure) 06/2015
1	Infarction (Infarctions) 06/2015
1	Thrombosis (Thrombus) 06/2015
1	Acute Liver Failure (Fulminant Hepatic Failure) 06/2015
1	Ischemia 06/2015
1	Hemorrhage 04/2015
1	Serum Sickness 11/2007
1	Pneumonia (Pneumonitis) 11/2007
1	Ileitis 09/2007

2	Budesonide (Pulmicort)FDA LinkGeneric 11/2015 - 04/2015
1	TroponinIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	Biosimilar PharmaceuticalsIBA 10/2018
1	Infliximab (Remicade)FDA Link 10/2017
1	Immunoglobulin A (IgA)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	N-formylmethionylphenylalanine (FMP)IBA 01/2017
1	Oxygen (Dioxygen)IBA 01/2017
1	16S Ribosomal RNAIBA 01/2017
1	AntimetabolitesIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2016
1	Methotrexate (Mexate)FDA LinkGeneric 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2015
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2015
1	Rifaximin (L 105)FDA Link 02/2013
1	phenylalanylarginineIBA 02/2013
1	Mesalamine (Mesalazine)FDA LinkGeneric 11/2007
1	Ribosomal DNA (rDNA)IBA 09/2007

2	Remission Induction 11/2015 - 04/2015
1	Premedication 10/2017
1	Fecal Microbiota Transplantation 01/2017
1	Biological Therapy 01/2017
1	Enema (Enemas) 01/2017
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 06/2015
1	Liver Transplantation 06/2015
1	Transjugular Intrahepatic Portasystemic Shunt 06/2015